About Jayakrishna Ambati
Jayakrishna Ambati is a co-founder and board member at Inflammasome Therapeutics.
Jayakrishna Ambati first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Jayakrishna Ambati in the role, so the role may have started earlier or lasted longer.
Inflammasome Therapeutics, Inc.
Co-Founder and Board Member
2023 – 2026 · Newton, MA
Develops experimental drugs for people with eye and degenerative diseases.
Key Colleagues at Startups
The people Jayakrishna Ambati works with at each company, as listed on that company's latest Form D.
Inflammasome Therapeutics, Inc. · Form D, May 4, 2026
Balamurali Ambati
Board Member
Chaniyilparampu Ramchand
Board Member
Babur Lateef
Chairman of the Board
Napoleone Ferrara
Board Member